Noticias de UTHR_US
Noticias del mercado
Últimas noticias sobre UTHR_US — 297 novedades recientes. Análisis, balances, opiniones y cobertura de prensa.
Weighted-average prices ranged from $547.2940 to $554.6997 in the September 30, 2026 sales under a trading plan adopted November 7, 2025.
Liquidia shares crater after court rules for United Therapeutics
Patient access programs help people with PH-ILD obtain Tyvaso or Tyvaso DPI as prescribed; both medicines are approved to improve exercise ability.
The $117.76 option exercise price applied to September 29 transactions under Rothblatt’s pre-arranged trading plan, which ends by December 31, 2026.
Investing.com -- Liquidia Corp shares fell Wednesday after a U.S. District Court in Delaware ruled the company infringed two patent claims held by United Therapeutics Corp. United Therapeutics shares rose more than 13%.
Investing.com -- Liquidia Corp shares fell Wednesday after a U.S. District Court in Delaware ruled the company infringed two patent claims held by United Therapeutics Corp. United Therapeutics shares rose more than 13%.
El fideicomiso realizó 14 ventas a precios promedio ponderados de 472,4274 dólares a 486,0050 dólares por acción. Posteriormente, su posición de opciones informada se situó en 347.410 acciones.
El fideicomiso ejerció opciones a 117,76 dólares por acción antes de venderlas a precios promedio ponderados que oscilaban entre 470,5565 dólares y 478,9522 dólares según un plan de negociación preestablecido.
Página 6 de 15